Skip to Main Content

Paper Details

Potential unrealized mortality benefit of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transport-2 inhibitors: A report from the Veterans Health Administration Clinical Assessment, Reporting and Tracking program.
Diabetes Obes Metab
1
2021
Author NameAffiliation
Stephen W WaldoRocky Mountain Regional VA Medical Center
Stephen W WaldoUniversity of Colorado School of Medicine
Pei Jai Michael HoRocky Mountain Regional VA Medical Center
Pei Jai Michael HoUniversity of Colorado School of Medicine
Pei Jai Michael Ho
  • 1 - 5

Datasets

Release 1.2